Field validation of clinical and laboratory diagnosis of wildebeest associated malignant catarrhal fever in cattle.
Herpesvirus
Kenya
No-gold standard
Wildebeest associated malignant catarrhal fever
Journal
BMC veterinary research
ISSN: 1746-6148
Titre abrégé: BMC Vet Res
Pays: England
ID NLM: 101249759
Informations de publication
Date de publication:
28 Feb 2019
28 Feb 2019
Historique:
received:
10
08
2018
accepted:
22
02
2019
entrez:
2
3
2019
pubmed:
2
3
2019
medline:
15
3
2019
Statut:
epublish
Résumé
Wildebeest associated malignant catarrhal fever (WA-MCF) is a fatal disease of cattle. Outbreaks are seasonal and associated with close interaction between cattle and calving wildebeest. In Kenya, WA-MCF has a dramatic effect on cattle-keepers who lose up to 10% of their cattle herds per year. The objective of this study was to report the impact of WA-MCF on a commercial ranch and assess the performance of clinical diagnosis compared to laboratory diagnosis as a disease management tool. A retrospective study of WA-MCF in cattle was conducted from 2014 to 2016 at Kapiti Plains Ranch Ltd., Kenya. During this period, 325 animals showed clinical signs of WA-MCF and of these, 123 were opportunistically sampled. In addition, 51 clinically healthy animals were sampled. Nested polymerase chain reaction (PCR) and indirect enzyme linked immunosorbent assay (ELISA) were used to confirm clinically diagnosed cases of WA-MCF. A latent class model (LCM) was used to evaluate the diagnostic parameters of clinical diagnosis and the tests in the absence of a gold standard. By PCR, 94% (95% C.I. 89-97%) of clinically affected animals were positive to WA-MCF while 63% (95% C.I. 54-71%) were positive by indirect ELISA. The LCM demonstrated the indirect ELISA had poor sensitivity 63.3% (95% PCI 54.4-71.7%) and specificity 62.6% (95% PCI 39.2-84.9%) while the nested PCR performed better with sensitivity 96.1% (95% PCI 90.7-99.7%) and specificity 92.9% (95% PCI 76.1-99.8%). The sensitivity and specificity of clinical diagnosis were 99.1% (95% PCI 96.8-100.0%) and 71.5% (95% PCI 48.0-97.2%) respectively. Clinical diagnosis was demonstrated to be an effective method to identify affected animals although animals may be incorrectly classified resulting in financial loss. The study revealed indirect ELISA as a poor test and nested PCR to be a more appropriate confirmatory test for diagnosing acute WA-MCF. However, the logistics of PCR make it unsuitable for field diagnosis of WA-MCF. The future of WA-MCF diagnosis should be aimed at development of penside techniques, which will allow for fast detection in the field.
Sections du résumé
BACKGROUND
BACKGROUND
Wildebeest associated malignant catarrhal fever (WA-MCF) is a fatal disease of cattle. Outbreaks are seasonal and associated with close interaction between cattle and calving wildebeest. In Kenya, WA-MCF has a dramatic effect on cattle-keepers who lose up to 10% of their cattle herds per year. The objective of this study was to report the impact of WA-MCF on a commercial ranch and assess the performance of clinical diagnosis compared to laboratory diagnosis as a disease management tool. A retrospective study of WA-MCF in cattle was conducted from 2014 to 2016 at Kapiti Plains Ranch Ltd., Kenya. During this period, 325 animals showed clinical signs of WA-MCF and of these, 123 were opportunistically sampled. In addition, 51 clinically healthy animals were sampled. Nested polymerase chain reaction (PCR) and indirect enzyme linked immunosorbent assay (ELISA) were used to confirm clinically diagnosed cases of WA-MCF. A latent class model (LCM) was used to evaluate the diagnostic parameters of clinical diagnosis and the tests in the absence of a gold standard.
RESULTS
RESULTS
By PCR, 94% (95% C.I. 89-97%) of clinically affected animals were positive to WA-MCF while 63% (95% C.I. 54-71%) were positive by indirect ELISA. The LCM demonstrated the indirect ELISA had poor sensitivity 63.3% (95% PCI 54.4-71.7%) and specificity 62.6% (95% PCI 39.2-84.9%) while the nested PCR performed better with sensitivity 96.1% (95% PCI 90.7-99.7%) and specificity 92.9% (95% PCI 76.1-99.8%). The sensitivity and specificity of clinical diagnosis were 99.1% (95% PCI 96.8-100.0%) and 71.5% (95% PCI 48.0-97.2%) respectively.
CONCLUSIONS
CONCLUSIONS
Clinical diagnosis was demonstrated to be an effective method to identify affected animals although animals may be incorrectly classified resulting in financial loss. The study revealed indirect ELISA as a poor test and nested PCR to be a more appropriate confirmatory test for diagnosing acute WA-MCF. However, the logistics of PCR make it unsuitable for field diagnosis of WA-MCF. The future of WA-MCF diagnosis should be aimed at development of penside techniques, which will allow for fast detection in the field.
Identifiants
pubmed: 30819152
doi: 10.1186/s12917-019-1818-8
pii: 10.1186/s12917-019-1818-8
pmc: PMC6396541
doi:
Substances chimiques
DNA, Viral
0
Types de publication
Journal Article
Validation Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
69Références
J Clin Microbiol. 2000 Apr;38(4):1313-8
pubmed: 10747100
Prev Vet Med. 2000 May 30;45(1-2):61-81
pubmed: 10802334
J Vet Diagn Invest. 2001 Jul;13(4):361-4
pubmed: 11478614
Res Vet Sci. 2002 Aug;73(1):93-9
pubmed: 12208112
J Virol Methods. 2005 Nov;129(2):186-90
pubmed: 15998545
J Am Vet Med Assoc. 2005 Aug 15;227(4):606-11
pubmed: 16117071
J Vet Diagn Invest. 2006 Jan;18(1):119-23
pubmed: 16566270
Vet Microbiol. 2006 Aug 25;116(1-3):21-8
pubmed: 16621342
BMC Vet Res. 2006 Oct 16;2:30
pubmed: 17042948
Prev Vet Med. 2007 Mar 17;78(3-4):296-316
pubmed: 17123651
Vet Rec. 2007 Nov 17;161(20):692-5
pubmed: 18024925
PLoS One. 2008 Feb 20;3(2):e1627
pubmed: 18286184
Vaccine. 2008 Aug 18;26(35):4461-8
pubmed: 18601965
Arch Virol. 2009;154(1):171-7
pubmed: 19066710
J S Afr Vet Assoc. 2008 Sep;79(3):136-41
pubmed: 19244822
Vet Microbiol. 2010 Jun 16;143(1):52-69
pubmed: 20346601
Int J Mol Sci. 2011;12(10):6881-93
pubmed: 22072925
Arch Virol. 1990;114(3-4):259-63
pubmed: 2241575
Vet Res. 2012 Jun 11;43:51
pubmed: 22686373
PLoS One. 2015 Jan 28;10(1):e0116059
pubmed: 25629896
Vet Res Forum. 2013 Spring;4(2):133-6
pubmed: 25653786
Arch Virol. 2016 Jan;161(1):1-10
pubmed: 26446889
Vaccine. 2016 Feb 3;34(6):831-8
pubmed: 26706270
Appl Psychol Meas. 2015 May;39(3):189-207
pubmed: 29881002
Biometrics. 1980 Mar;36(1):167-71
pubmed: 7370371
J Clin Microbiol. 1994 Jul;32(7):1674-9
pubmed: 7523438
J Wildl Dis. 1996 Jul;32(3):437-43
pubmed: 8827669
J Clin Epidemiol. 1998 Sep;51(9):763-71
pubmed: 9731925
J Clin Microbiol. 1998 Oct;36(10):2970-2
pubmed: 9738052